Charles River Laboratories International, Inc. | Mid-cap | Healthcare
$157.49
2.00%
| Charles River Stock Comparison:
Charles River vs Thermo FisherCharles River vs DanaherCharles River vs Qiagen N.VCharles River vs Medpace HoldingsCharles River vs Guardant HealthCharles River vs S&P 500 | Market
Overview Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 4.0B
Gross Profit 1.3B 32.88%
Operating Income 442.3M 10.92%
Net Income 25.3M 0.62%
EPS (Diluted) $0.20

Balance Sheet Metrics

Total Assets 7.5B
Total Liabilities 4.0B
Shareholders Equity 3.5B
Debt to Equity 1.15

Cash Flow Metrics

Operating Cash Flow 420.0M
Free Cash Flow 501.6M

Revenue & Profitability Trend

Charles River Income Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Revenue 4.0B 4.1B 4.0B 3.5B 2.9B
Cost of Goods Sold 2.7B 2.6B 2.5B 2.2B 1.9B
Gross Profit 1.3B 1.5B 1.5B 1.3B 1.1B
Operating Expenses 751.0M 747.9M 665.1M 619.9M 528.9M
Operating Income 442.3M 617.3M 651.0M 589.9M 432.7M
Pre-tax Income 93.1M 581.3M 623.0M 480.7M 447.1M
Income Tax 67.8M 100.9M 130.4M 81.9M 81.8M
Net Income 25.3M 480.4M 492.6M 398.8M 365.3M
EPS (Diluted) $0.20 $9.22 $9.48 $7.60 $7.20

Income Statement Trend

Charles River Balance Sheet From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Assets
Current Assets 1.4B 1.6B 1.4B 1.3B 1.2B
Non-Current Assets 6.1B 6.6B 6.2B 5.8B 4.3B
Total Assets 7.5B 8.2B 7.6B 7.0B 5.5B
Liabilities
Current Liabilities 994.1M 1.1B 1.1B 1.0B 839.8M
Non-Current Liabilities 3.0B 3.5B 3.5B 3.4B 2.5B
Total Liabilities 4.0B 4.5B 4.6B 4.4B 3.3B
Equity
Total Shareholders Equity 3.5B 3.7B 3.0B 2.6B 2.1B

Balance Sheet Composition

Charles River Cash Flow Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Operating Activities
Net Income 25.3M 480.4M 492.6M 398.8M 365.3M
Operating Cash Flow 420.0M 704.2M 741.8M 678.7M 603.3M
Investing Activities
Capital Expenditures - - - - -
Investing Cash Flow -12.1M -244.6M -283.2M -1.2B -435.0M
Financing Activities
Dividends Paid - - - - -
Financing Cash Flow -574.8M -111.1M -67.5M 626.9M 662.0K
Free Cash Flow 501.6M 365.4M 294.9M 532.0M 380.0M

Cash Flow Trend

Charles River Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 681.33
Forward P/E 14.34
Price to Book 2.27
Price to Sales 1.80
PEG Ratio 14.34

Profitability Ratios

Profit Margin -0.49%
Operating Margin 13.62%
Return on Equity -0.67%
Return on Assets 4.27%

Financial Health

Current Ratio 1.43
Debt to Equity 92.21
Beta 1.48

Per Share Data

EPS (TTM) -$0.60
Book Value per Share $65.04
Revenue per Share $78.58

Peer Financial Comparison

Company Market Cap P/E Ratio P/B Ratio ROE Profit Margin Debt/Equity
crl 7.2B 681.33 2.27 -0.67% -0.49% 92.21
Thermo Fisher 152.5B 23.69 3.09 13.70% 15.19% 69.23
Danaher 140.5B 37.98 2.76 7.22% 15.81% 34.56
Qiagen N.V 10.1B 108.63 2.97 2.67% 4.68% 41.36
Medpace Holdings 8.9B 23.58 15.48 65.83% 19.31% 25.33
Guardant Health 6.0B -14.19 -24.95 312.48% -53.82% -5.21

Financial data is updated regularly. All figures are in the company's reporting currency.